Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Comparative effectiveness inventory

This article was originally published in The Gray Sheet

Executive Summary

The Department of Health and Human Services is 1requesting public comment through Aug. 9 on development of a comparative effectiveness research "inventory" of ongoing and completed research for public consumption. HHS agencies have posted information on research projects stemming from the $1.1 billion in comparative effectiveness funding provided by economic stimulus legislation (2"The Gray Sheet" Jan. 11, 2010), but the agency is trying to develop a more comprehensive and accessible database. Comments are requested on appropriate sources of research for inclusion in the inventory, incentives for encouraging participation, methods for categorizing content and strategies to ensure that the inventory is "useful and sustainable over time.

You may also be interested in...

HHS Plans To Use Four Primary Sources For Online CER Inventory

The HHS Office of the Assistant Secretary for Planning and Evaluation will be using four primary sources to fill a planned online inventory of comparative effectiveness research.

AdvaMed Encourages HHS CER Inventory Efforts; Drug Groups Press For Delay

AdvaMed is encouraging Health and Human Services' efforts to start building a centralized inventory of comparative effectiveness research, even as drug industry groups complain the project would be "premature" before a congressionally established public-private institute gets up and running

Device Comparative Effectiveness Studies Received $40 Mil. From NIH In '09

The National Institutes of Health handed out about $40 million of its comparative effectiveness research funds in 2009 to studies directly impacting devices, with more than two-thirds of that money targeting medical imaging or in vitro diagnostics applications

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts